Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 142 No. 2728 (2012)

Drug-related problems and factors influencing acceptance of clinical pharmacologists’ alerts in a large cohort of neurology inpatients

  • Anne B Taegtmeyer
  • Ivanka Curkovic
  • Natascia Corti
  • Christoph Rosen
  • Marco Egbring
  • Stefan Russmann
  • Andreas R Gantenbein
  • Michael Weller
  • Gerd A Kullak-Ublick
DOI
https://doi.org/10.4414/smw.2012.13615
Cite this as:
Swiss Med Wkly. 2012;142:w13615
Published
01.07.2012

Summary

QUESTIONS UNDER STUDY/PRINCIPLES: Data regarding the prevalence and types of drug-related problems (DRPs) among neurology inpatients is sparse. The objective of this study was to characterise the types of DRPs seen among neurology inpatients and furthermore to study factors affecting the acceptance of clinical pharmacologists’ and pharmacists’ recommendations for improving drug safety.

METHODS: 1,263 consecutive inpatient cases in a Swiss university hospital neurology unit were assessed for the presence of DRPs over 12 months. Treating neurologists’ acceptance of the resulting recommendations was also recorded. Primary outcome measures were types of DRP, recommendations made by clinical pharmacologists and number of recommendations accepted. Factors potentially associated with acceptance were studied using univariate and multivariate generalised estimating equation modelling.

RESULTS: Twenty-nine percent of cases demonstrated one or more DRPs. DRPs were the cause of admission in 10 cases (0.8%). In total 494 DRPs were identified and 467 recommendations given, of which 62% were accepted. Factors associated with an increased likelihood of acceptance were prescriptions involving regularly administered drugs (odds ratio [OR] 2.57 95% confidence interval [CI] 1.73–3.80), adverse drug events (OR 2.5; 95% CI 1.29–5.06), known drug side-effect (OR 1.85; 95% CI 1.06–3.22), high-risk drug-drug interactions (OR 3.22; 95% CI 1.07–9.69) and interventions involving changing a drug (OR 2.71; 95% CI 1.17–6.25).

CONCLUSION: Clinical pharmacologists and pharmacists can play an important role in identifying DRPs among neurology inpatients. Their recommendations for optimising medication-safety are most likely to be accepted for regular prescriptions, prescriptions associated with an adverse drug event and high-risk drug combinations.

References

  1. Bladh L, Ottosson E, Karlsson J, et al. Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf. 2011;20:738–46.
  2. Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34:319–27.
  3. Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.
  4. Taegtmeyer AB, Curkovic I, Rufibach K, et al. Electronic prescribing increases uptake of clinical pharmacologists’ recommendations in the hospital setting. Br J Clin Pharmacol. 2011;72:958–64
  5. http://www.pharmavista.ch/content/default.aspx accessed 18th October 2010
  6. Hansten PD, Horn JR, Hazlet TK. ORCA: OpeRational ClassificAtion of drug interactions. J Am Pharm Assoc. (Wash) 2001;41:161–5.
  7. Classification for Drug-Related Problems V6.2 (revised 14-01-2010) http://www.pcne.org/sig/drp/documents/drp/PCNE%20classification%20V6-2.pdf. Pharmaceutical Care Network Europe Foundation [November 2011]
  8. Micromedex® Healthcare Series, Thomson Reuters, Greenwood Village, Colorado (Edition expired 2010).
  9. Halekoh U, Hojsgaard S, Yan J. The R Package geepack for Generalized Estimating Equations. J Stat Softw. 2006;15:1–11.
  10. Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651–8.
  11. Chan DC, Chen JH, Kuo HK, et al. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54:168–74.
  12. Bjornson DC, Hiner WO, Jr., Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875–84.
  13. Krahenbuhl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30:379–407.
  14. Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical inpatients. Swiss Med Wkly. 2004;134:664–70.
  15. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.
  16. Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med. 2009;169:305–11.
  17. Mille F, Schwartz C, Brion F, et al. Analysis of overridden alerts in a drug-drug interaction detection system. Int J Qual Health Care. 2008;20:400–5.
  18. Guzek M, Zorina OI, Semmler A, et al. Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System). Pharmacoepidemiol Drug Saf. 2011;20:930–8.
  19. Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.
  20. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci. 2008;30:128–35.
  21. de Almeida Neto AC, Chen TF. When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making. Pharm World Sci. 2008;30:3–8.

Most read articles by the same author(s)